The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs

NCT01800487 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: silymarin
DRUG: Placebo

Sponsor

Ramathibodi Hospital